Yazılar

Cognizant Increases Share Buyback Plan by $2 Billion Amid Economic Challenges

Cognizant Technology (CTSH.O) announced on Tuesday that its board has approved a $2 billion increase to its existing share repurchase program, bringing the total authorized amount to $3.1 billion. The company now expects to repurchase $1.1 billion worth of shares this year, a $500 million increase over previous expectations.

This move comes as part of Cognizant’s ongoing efforts to enhance shareholder returns, despite facing challenges in the IT services market. Shares of the company rose 1.7% in early trading following the announcement. Cognizant is set to host its investor day later today, where it will unveil its long-term growth strategies, including plans to improve its artificial intelligence (AI) offerings.

The company has been grappling with fluctuating IT services demand due to economic uncertainty and high interest rates, which have put pressure on enterprise budgets and caused clients to reduce spending. This uncertainty led to Cognizant lowering its annual revenue forecast last month, falling short of analysts’ expectations.

In addition to these financial concerns, Cognizant is also dealing with activist investor involvement from Mantle Ridge, which has been in discussions with the company since mid-2024. The Wall Street Journal reported earlier this month that Mantle Ridge has acquired a stake worth more than $1 billion in Cognizant and has been privately engaging with the company to address its performance and share price growth.

OpenAI Appoints Brad Lightcap as COO to Lead Global Expansion Efforts

OpenAI’s Chief Operating Officer, Brad Lightcap, has been tasked with leading the company’s global expansion and corporate partnerships, as the AI startup looks to solidify its position in the rapidly evolving artificial intelligence industry. CEO Sam Altman made the announcement on Monday, noting that Lightcap will focus on business strategy, key partnerships, infrastructure, and operational excellence to enhance the impact of OpenAI’s research.

As Lightcap takes on a more prominent role in overseeing business operations, Altman will shift his attention toward the technical side of the company, concentrating on advancing research and product initiatives. Altman remains in charge of OpenAI’s overall direction.

In addition to these leadership changes, OpenAI is collaborating with SoftBank Group and Oracle on the $500-billion Stargate project, which involves creating a network of data centers designed to support AI workloads. The initiative is part of OpenAI’s broader efforts to scale its operations and power cutting-edge AI research.

Lightcap, who previously worked with Altman at Y Combinator, has been with OpenAI since 2018. He will now lead the company’s global deployment strategy. Furthermore, OpenAI has also expanded the responsibilities of Chief Research Officer Mark Chen, who will integrate research and product development more closely.

Altman recently shared that OpenAI is working on simplifying its products, a move aimed at attracting new investments amid rising scrutiny over its substantial spending on AI development. The company is in the process of raising $40 billion as it transitions into a for-profit entity to secure the necessary capital to advance its AI models. In October, OpenAI closed a $6.6 billion funding round to fuel its growth.

SAP Overtakes Novo Nordisk as Europe’s Largest Company by Market Capitalization

German software giant SAP has surpassed Danish healthcare company Novo Nordisk as Europe’s largest company by market capitalization. As of 0900 GMT on Monday, SAP’s market cap stood at $340 billion, edging out Novo Nordisk, according to Reuters’ calculations using LSEG Workspace data.

SAP, Europe’s leading software maker, specializes in business application software, serving various industries in functions like finance, sales, and supply chain management. Its growth is largely attributed to optimism surrounding its cloud business, with expectations that it will benefit significantly from recent investments in generative artificial intelligence. Despite a 7% increase in SAP’s stock price in 2025, which lags behind the broader European STOXX 600 index’s 8.3% rise year-to-date, the company has posted a remarkable 160% total return since the end of 2022, far outpacing the STOXX 600’s 28% performance.

In contrast, Novo Nordisk has seen recent underperformance, especially after disappointing trial results from its experimental obesity drug, Cagrisema. The healthcare company had previously surpassed luxury goods giant LVMH in September 2023 to become Europe’s largest company but has since struggled to maintain that lead.